Serum Institute of India
-
Coronavirus: Adar Poonawalla warns of raw material shortage for vaccine production due to US law
Scroll Staff
-
Madras HC issues notice to Centre, Serum Institute as volunteer alleges serious trial side effects
Scroll Staff
-
Coronavirus: Hope to launch Covovax vaccine by June, says Serum Institute CEO Adar Poonawalla
Scroll Staff
-
Pune Police, three Maharashtra government agencies start inquiry into Serum Institute fire
Scroll Staff
-
Serum Institute fire: Over Rs 1,000-crore worth damages incurred, says CEO Adar Poonawalla
Scroll Staff
-
Five dead after massive fire at Pune’s Serum Institute plant, Adar Poonawalla says ‘deeply saddened’
Scroll Staff
-
Coronavirus: Serum, Bharat Biotech pledge smooth rollout of vaccine a day after public spat
Scroll Staff
-
Coronavirus: Export of Covishield allowed to all countries, says Serum CEO Adar Poonawalla
Scroll Staff
-
The big news: Two coronavirus vaccines cleared for emergency use in India, and 9 other top stories
Scroll Staff
-
Covid-19: Serum vaccine to be used in first phase, Bharat Biotech shot back-up, says AIIMS director
Scroll Staff
-
Coronavirus: India approves vaccines by Serum Institute, Bharat Biotech for restricted emergency use
Scroll Staff
-
The big news: Expert panel clears Covaxin, Covishield for emergency use, and nine other top stories
Scroll Staff
-
Coronavirus: Expert panel recommends Bharat Biotech, Serum Institute vaccines to drug regulator
Scroll Staff
-
Coronavirus: Centre needs to protect vaccine makers against lawsuits, says Serum Institute chief
Scroll Staff
-
Covid vaccine: Bharat Biotech, Serum Institute have applied for emergency use, confirms Centre
Scroll Staff
-
Serum Institute’s trial has run into a controversy. Will this erode public trust in a vaccine?
Arunabh Saikia
-
Vaccine trial participant sues Serum Institute for ‘severe adverse effect’, DCGI begins inquiry
Scroll Staff
-
Covid-19: PM Modi likely to visit Serum Institute on Saturday to take stock of vaccine production
Scroll Staff
-
Coronavirus vaccine could roll out in three to four months, says Serum Institute CEO
Scroll Staff
-
Coronavirus: India to get 10 crore doses of Oxford vaccine next month, says Serum Institute CEO
Scroll Staff